Breaking News Instant updates and real-time market news.

2023-01-31 10:10:34 PBLA Panbela Therapeutics $1.74 / +0.15 (+9.43%) 10:10 01/31/23 01/31 10:10 01/31/23 10:10	Panbela Therapeutics resumed with a Buy at Roth Capital Roth Capital analyst Jonathan Aschoff resumed coverage of Panbela Therapeutics with a Buy rating and $10 price target. Given Panbela's Q2 acquisition of CPP, it now has several opportunities to create value over the next year, in addition to its original primary value driver of Q1 2024 interim Phase 3 results with SBP-101 in first-line metastatic PDA, the firm says. Roth also notes that Flynpovi is in Phase 3 for colon cancer risk prevention and Phase 3 in FAP starts in the second half of 2023, a design informed by a prior Phase 3.	12 Mar 26 Jan

2023-01-31 10:10:34

PBLA

Panbela Therapeutics

$1.74 / +0.15 (+9.43%)

10:10

01/31/23

01/31

10:10

01/31/23

10:10

Panbela Therapeutics resumed with a Buy at Roth Capital

Roth Capital analyst Jonathan Aschoff resumed coverage of Panbela Therapeutics with a Buy rating and $10 price target. Given Panbela's Q2 acquisition of CPP, it now has several opportunities to create value over the next year, in addition to its original primary value driver of Q1 2024 interim Phase 3 results with SBP-101 in first-line metastatic PDA, the firm says. Roth also notes that Flynpovi is in Phase 3 for colon cancer risk prevention and Phase 3 in FAP starts in the second half of 2023, a design informed by a prior Phase 3.

12
Mar

26
Jan

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Microsoft price target raised to $375 from $340 at Wedbush » 07:41 05/30/23 05/30 07:41 05/30/23 07:41 MSFT Microsoft $332.87 / +6.92 (+2.12%) Wedbush analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:41 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT Microsoft $332.87 / +6.92 (+2.12%) 05:05 Today BHP Group, Microsoft enter copper recovery collaboration 05/29/23 Fly Intel: Top five weekend stock stories 05/29/23 Nvidia announces DGX GH200 AI supercomputer 05/24/23 Microsoft says 'Volt Typhoon' targeting U.S. infrastructure via Fortinet devices MSFT Microsoft $332.87 / +6.92 (+2.12%) 05/26/23 Wolfe Research Wolfe downgrades Snowflake amid growing competition from Microsoft 05/25/23 Oppenheimer Microsoft Azure OpenAI customers up 80% since last month, says Oppenheimer 05/24/23 BofA Google's three pillars 'still upright' despite Bing in ChatGPT, says BofA 05/24/23 Mizuho Microsoft price target raised to $340 from $325 at Mizuho MSFT Microsoft $332.87 / +6.92 (+2.12%) 04/25/23 Microsoft reports Q3 EPS $2.45, consensus $2.23 04/25/23 Microsoft reports Q3 EPS $2.45, consensus $2.23 04/25/23 Notable companies reporting after market close 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 MSFT Microsoft $332.87 / +6.92 (+2.12%) 05/29/23 Microsoft's $75B bid for Activision Blizzard hinges on Call of Duty, WSJ says 05/25/23 EU, UK disagreeing on Microsoft deal 'raises questions,' Bloomberg reports 05/24/23 Microsoft appeals U.K.'s decision to block Activision deal, Sky News reports 05/19/23 China's SAMR gives approval to Microsoft-Activision tie-up, Dealreporter says MSFT Microsoft $332.87 / +6.92 (+2.12%) 05/24/23 #SocialStocks: Meta fined EUR 1.2B in Ireland for infringing on data laws 05/23/23 What You Missed This Week in Video Games 05/22/23 Here's what Wall St. experts are saying about Zoom Video ahead of earnings 05/19/23 What You Missed On Wall Street This Morning 05/31/23 Software Conference MSFT Microsoft $332.87 / +6.92 (+2.12%) 05/26/23 Notable open interest changes for May 26th 04/27/23 Notable open interest changes for April 27th 04/26/23 Early notable gainers among liquid option names on April 26th 04/26/23 Notable open interest changes for April 26th
Earnings	CureVac reports Q1 revenue EUR 7.1M vs. EUR 24.4M last year » 07:40 05/30/23 05/30 07:40 05/30/23 07:40 CVAC CureVac $9.15 / -0.27 (-2.87%) Reports Q1 operating loss… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:40 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options CVAC CureVac $9.15 / -0.27 (-2.87%) 05/19/23 CureVac granted motion to transfer U.S. litigation with Pfizer, BioNTech 05/08/23 CureVac doses first patient in Phase 1/2 study of influenza vaccine candidates 04/25/23 CureVac sees cash reach to mid-2025 02/01/23 CureVac appoints Myriam Mendila as CDO CVAC CureVac $9.15 / -0.27 (-2.87%) 04/26/23 JMP Securities CureVac price target lowered to $24 from $34 at JMP Securities 01/30/23 JMP Securities JMP Securities says older-adult update continues to look encouraging for CureVac 01/19/23 UBS UBS upgrades CureVac after 'major milestone and clearing event' 01/19/23 UBS CureVac upgraded to Buy from Neutral at UBS CVAC CureVac $9.15 / -0.27 (-2.87%) 04/25/23 CureVac reports Q4 revenue EUR 11.7M vs. EUR 41.2M last year 08 Feb CVAC CureVac $9.15 / -0.27 (-2.87%) 01/19/23 What You Missed On Wall Street On Thursday 01/19/23 What You Missed On Wall Street This Morning 01/19/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/19/23 Fly Intel: Pre-market Movers CVAC CureVac $9.15 / -0.27 (-2.87%) 02/10/23 Largest borrow rate increases among liquid names
Recommendations	Lantheus thesis unchanged after competitor approval, says Jefferies » 07:40 05/30/23 05/30 07:40 05/30/23 07:40 LNTH Lantheus $91.06 / -6.855 (-7.00%) Jefferies analyst Matthew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:40 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/23/23 Lantheus announces payment to CVR holders of $1.15 per CVR 04/24/23 Lantheus, Point Biopharma announces FDA grants FTD for 177Lu-PNT2002 03/17/23 Lantheus appoints Paul Blanchfield as president, Dan Niedzwiecki as CAO 02/16/23 Lantheus presents data on piflufolastat F 18 at 2023 ASCO symposium LNTH Lantheus $91.06 / -6.855 (-7.00%) 06:42 Today Mizuho Lantheus selloff on competitor approval overdone, says Mizuho 05/05/23 SVB Securities Lantheus price target raised to $127 from $120 at SVB Securities 05/05/23 Truist Lantheus price target raised to $125 from $115 at Truist 05/05/23 JMP Securities Lantheus price target raised to $130 from $120 at JMP Securities LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/04/23 Lantheus sees 2023 adjusted EPS $5.45-$5.70, consensus $4.95 05/04/23 Lantheus sees Q2 adjusted EPS $1.25-$1.33, consensus $1.21 05/04/23 Lantheus reports Q1 adjusted EPS $1.47, consensus $1.26 02/23/23 Lantheus sees FY23 adjusted EPS $4.95 - $5.10, consensus $4.21 LNTH Lantheus $91.06 / -6.855 (-7.00%) 03/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/23/23 What You Missed On Wall Street On Thursday 02/23/23 What You Missed On Wall Street This Morning
Initiation	Fortuna Silver Mines resumed with a Sector Perform at Scotiabank » 07:40 05/30/23 05/30 07:40 05/30/23 07:40 FSM Fortuna Silver Mines $3.25 / +0.02 (+0.62%) Scotiabank resumed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:40 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options FSM Fortuna Silver Mines $3.25 / +0.02 (+0.62%) 05/11/23 Fortuna Silver Mines announces blockade lifted at San Jose Mine 05/02/23 Fortuna Silver Mines reports an illegal blockade at San Jose Mine, Mexico 04/28/23 Fortuna Silver Mines to purchase up to 5% of outstanding shares in NCIB 04/12/23 Fortuna Silver Mines reports Q1 gold production 60,092 ounces, down 10% FSM Fortuna Silver Mines $3.25 / +0.02 (+0.62%) 05/19/23 National Bank Fortuna Silver Mines price target raised to C$7.25 from C$7 at National Bank 04/18/23 National Bank Fortuna Silver Mines price target raised to C$7 from C$6 at National Bank 03/23/23 National Bank Fortuna Silver Mines price target raised to C$6 from C$5.75 at National Bank 02/14/23 National Bank Fortuna Silver Mines price target lowered to C$5.75 from C$6 at National Bank FSM Fortuna Silver Mines $3.25 / +0.02 (+0.62%) 03/16/23 Fortuna Silver Mines reports Q4 adjusted EPS 2c, consensus 2c FSM Fortuna Silver Mines $3.25 / +0.02 (+0.62%) 05/15/23 Fortuna Silver Mines options imply 4.1% move in share price post-earnings 03/15/23 Fortuna Silver Mines options imply 5.7% move in share price post-earnings 01/24/23 Largest borrow rate increases among liquid names 01/19/23 Largest borrow rate increases among liquid names
Hot Stocks	Genprex's Reqorsa combination in lung cancer approved for Phase 2 » 07:39 05/30/23 05/30 07:39 05/30/23 07:39 GNPX Genprex / + Genprex has completed the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:39 Get Free Trial ShowHide Related Items >><< Company News Street Research Events GNPX Genprex / + 05/25/23 Genprex publishes positive clinical data from REQORSA trial in NSCLC at ASCO 04/19/23 Genprex announces preclinical data from studies with ONCOPREX 01/05/23 Genprex enters license agreement with University of Pittsburgh 12/15/22 Genprex licenses additional gene technology from University of Pittsburgh GNPX Genprex / + 01/30/23 Dawson James Genprex initiated with a Buy at Dawson James 06/27/23 Genprex, Inc.
Recommendations	Boise Cascade price target raised to $98 from $91 at DA Davidson » 07:38 05/30/23 05/30 07:38 05/30/23 07:38 BCC Boise Cascade $75.45 / +0.525 (+0.70%) DA Davidson analyst Kurt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:38 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals BCC Boise Cascade $75.45 / +0.525 (+0.70%) 05/09/23 Boise Cascade expands Birmingham, AL distribution center 05/04/23 Boise Cascade announces special dividend of $3.00 per share 02/21/23 Boise Cascade to manage production levels to meet current, expected demand 01/23/23 Boise Cascade plans door shop facility in Kansas City BCC Boise Cascade $75.45 / +0.525 (+0.70%) 05/16/23 BMO Capital Boise Cascade price target raised to $78 from $72 at BMO Capital 05/08/23 DA Davidson Boise Cascade price target raised to $91 from $83 at DA Davidson 05/07/23 BofA Boise Cascade price target lowered to $65 from $68 at BofA 10/13/22 BofA Boise Cascade downgraded to Underperform on housing risk at BofA BCC Boise Cascade $75.45 / +0.525 (+0.70%) 05/04/23 Boise Cascade reports Q1 EPS $2.43, consensus $1.67 02/21/23 Boise Cascade reports Q4 EPS $2.95, consensus $2.96 BCC Boise Cascade $75.45 / +0.525 (+0.70%) 04/27/23 Lumber prices fall amid pending home sales slump, Business Insider says
Hot Stocks	Skyharbour signs option agreement with North Shore Energy Metals » 07:38 05/30/23 05/30 07:38 05/30/23 07:38 CLOE Clover Leaf Capital $11.26 / +0.06 (+0.54%) Skyharbour Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:38 Get Free Trial ShowHide Related Items >><< Company News CLOE Clover Leaf Capital $11.26 / +0.06 (+0.54%) 07:15 Today Clover Leaf Capital announces option agreement between North Shore, Skyharbour 12/23/22 Clover Leaf Capital announces definitive agreement for qualifying transaction
Hot Stocks	Revive Therapeutics provides update on phase 3 study of bucillamine » 07:36 05/30/23 05/30 07:36 05/30/23 07:36 RVVTF Revive Therapeutics / + Revive Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:36 Get Free Trial ShowHide Related Items >><< Company News RVVTF Revive Therapeutics / + 05/12/23 Revive halts Phase 3 study of bucillamine following DSMB recommendation 04/03/23 Revive Therapeutics purchases MDMA supply from PharmAla Biotech 03/28/23 Revive enrolls patient in psilocybin study for methamphetamine use disorder 03/20/23 Revive Therapeutics: Phase 3 study for bucillamine to retain current endpoint
Hot Stocks	Akebia receives response from FDA on path forward for vadadustat submission » 07:35 05/30/23 05/30 07:35 05/30/23 07:35 AKBA Akebia $1.13 / -0.095 (-7.79%) Akebia received a written… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:35 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AKBA Akebia $1.13 / -0.095 (-7.79%) 05/25/23 Akebia enters license agreement with Medice Arzneimittel Putter for Vafseo 05/22/23 Akebia regains compliance with Nasdaq minimum bid price requirement 05/22/23 Akebia's Vafseo approved in the U.K. for anemia associated with kidney disease 04/25/23 Akebia receives European Commission approval for Vafseo AKBA Akebia $1.13 / -0.095 (-7.79%) 04/26/23 H.C. Wainwright Akebia price target raised to $2 from $1.25 at H.C. Wainwright 02/02/23 Piper Sandler Akebia should update on vadadustat FDA process in next month, says Piper Sandler AKBA Akebia $1.13 / -0.095 (-7.79%) 05/08/23 Akebia reports Q1 EPS (14c) vs. (35c) last year 03/09/23 Akebia sees 2023 net product guidance $175M-$180M vs. $177.1M in 2022 03/09/23 Akebia reports Q4 EPS (4c), consensus (19c) AKBA Akebia $1.13 / -0.095 (-7.79%) 05/24/23 Biotech Alert: Searches spiking for these stocks today 06/06/23 Akebia Therapeutics, Inc.
Recommendations	Fluor's earnings potential not reflected in share price, says DA Davidson » 07:35 05/30/23 05/30 07:35 05/30/23 07:35 FLR Fluor $27.20 / +0.415 (+1.55%) DA Davidson analyst Brent… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:35 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FLR Fluor $27.20 / +0.415 (+1.55%) 04/18/23 Fluor signs MOU with Longview to serve as engineering, construction partner 04/18/23 Fluor signs MOU with Longview Fusion Energy Systems for laser fusion power 04/17/23 Fluor's joint venture awarded contract by U.S. DOE 04/13/23 BWX, Fluor in group awarded DOE contract worth up to $45B FLR Fluor $27.20 / +0.415 (+1.55%) 05/08/23 Baird Fluor price target lowered to $40 from $43 at Baird 02/22/23 Baird Fluor price target raised to $43 from $38 at Baird 11/29/22 UBS Fluor price target raised to $36 from $26 at UBS 11/14/22 Baird Fluor price target raised to $37 from $32 at Baird FLR Fluor $27.20 / +0.415 (+1.55%) 05/05/23 Fluor backs FY26 adjusted EPS view $3.10-$3.60 05/05/23 Fluor backs FY23 adjusted EPS view $1.50-$1.90, consensus $1.66 05/05/23 Fluor reports Q1 adjusted EPS 28c, consensus 37c 02/21/23 Fluor sees FY23 adjusted EPS $1.50-$1.90, consensus $1.66 FLR Fluor $27.20 / +0.415 (+1.55%) 02/21/23 Fly Intel: Pre-market Movers 00:00 Today Industrials & Basic Materials Conference

Initiation	Acelyrin initiated with a Buy at Jefferies » 07:35 05/30/23 05/30 07:35 05/30/23 07:35 SLRN Acelyrin $19.25 / -0.26 (-1.33%) Jefferies initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:35 Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly Options SLRN Acelyrin $19.25 / -0.26 (-1.33%) 05:48 Today TD Cowen Acelyrin initiated with an Outperform at TD Cowen 04:49 Today Piper Sandler Acelyrin initiated with an Overweight at Piper Sandler 05 May SLRN Acelyrin $19.25 / -0.26 (-1.33%) 05/07/23 Opening Day: J&J's Kenvue jumps 20% in market debut SLRN Acelyrin $19.25 / -0.26 (-1.33%) 05/22/23 Three new option listings and one option delisting on May 22nd
Hot Stocks	Vision Marine secures industrial tooling to meet demand of marine industry » 07:34 05/30/23 05/30 07:34 05/30/23 07:34 VMAR Vision Marine Technologies $3.80 / -0.12 (-3.06%) Vision Marine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:34 Get Free Trial ShowHide Related Items >><< Company News VMAR Vision Marine Technologies $3.80 / -0.12 (-3.06%) 04/04/23 Vision Marine Technologies names Murray as Chairman 03/02/23 Vision Marine announces opening of second electric boat rental in California 02/06/23 Vision Marine, Four Winns to showcase H2e Electric Bowrider at MIBS 01/27/23 Vision Marine Technologies announces closing of registered direct offering
Hot Stocks	Stronghold Digital Mining reaches hash rate of 3.0 EH/s » 07:34 05/30/23 05/30 07:34 05/30/23 07:34 SDIG Stronghold Digital Mining $6.05 / -0.19 (-3.04%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:34 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SDIG Stronghold Digital Mining $6.05 / -0.19 (-3.04%) 05/15/23 Stronghold Digital Mining announces 1-for-10 reverse stock split 05/04/23 Stronghold Digital Mining enters two-year hosting agreement with Cantaloupe 04/26/23 Coinbase, Talos partner on solutions for institutional digital asset demand 04/21/23 Stronghold Digital Mining purchases 5,000 MicroBT Whatsminer M50 miners SDIG Stronghold Digital Mining $6.05 / -0.19 (-3.04%) 04/19/23 B. Riley Stronghold Digital Mining price target raised to $1 from 50c at B. Riley 04/14/23 Compass Point Stronghold Digital Mining price target raised to $2.25 from $1.50 at Compass Point 03/30/23 Compass Point Stronghold Digital Mining price target raised to $1.50 from $1.00 at Compass Point 03/30/23 H.C. Wainwright Stronghold Digital Mining price target lowered to $2 from $3 at H.C. Wainwright SDIG Stronghold Digital Mining $6.05 / -0.19 (-3.04%) 05/11/23 Stronghold Digital Mining reports Q1 EPS (65c), consensus (14c) 03/29/23 Stronghold Digital Mining reports Q4 EPS (74c), consensus (36c) 03/22/23 Stronghold Digital sees Q4 revenue $23M, consensus $19.96M SDIG Stronghold Digital Mining $6.05 / -0.19 (-3.04%) 05/08/23 U.S. exchanges list over a dozen cryptos that SEC deem illegal to sell, WSJ says 02/14/23 Senator Elizabeth Warren assembles an anti-crypto army, Politico says 01/24/23 SEC thwarts aspiring crypto companies form public listings in 2022, WSJ says 01/05/23 Crypto-trading firm Genesis lays off 30% more staff, CoinDesk reports SDIG Stronghold Digital Mining $6.05 / -0.19 (-3.04%) 05/12/23 Here's What You Missed in Crypto This Week 05/05/23 Here's What You Missed in Crypto This Week 04/21/23 Here's What You Missed in Crypto This Week 04/14/23 Here's What You Missed in Crypto This Week 06/15/23 Stronghold Digital Mining, Inc.
Recommendations	Iovance Biotherapeutics price target raised to $24 from $21 at Stifel » 07:34 05/30/23 05/30 07:34 05/30/23 07:34 IOVA Iovance Biotherapeutics $7.54 / -0.15 (-1.95%) Stifel analyst Benjamin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:34 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events IOVA Iovance Biotherapeutics $7.54 / -0.15 (-1.95%) 05/26/23 Iovance Biotherapeutics announces FDA acceptance of BLA of Lifileucel 03/24/23 Iovance Biotherapeutics completes BLA submission for lifileucel 03/10/23 Iovance says it does not hold deposits, securities at Silicon Valley Bank 01/23/23 Clinigen divests Proleukin to Iovance Biotherapeutics for GBP 166.7M IOVA Iovance Biotherapeutics $7.54 / -0.15 (-1.95%) 05/29/23 Barclays Iovance news 'important clearing event' for shares, says Barclays 05/23/23 Baird Iovance Biotherapeutics price target raised to $23 from $20 at Baird 05/10/23 Baird Iovance Biotherapeutics price target lowered to $20 from $25 at Baird 03/27/23 Stifel Stifel leans positive on approval of Iovance's BLA submission for lifileucel IOVA Iovance Biotherapeutics $7.54 / -0.15 (-1.95%) 05/09/23 Iovance Biotherapeutics reports Q1 EPS (50c), consensus (74c) 02/28/23 Iovance Biotherapeutics reports Q4 EPS (64c), consensus (64c) IOVA Iovance Biotherapeutics $7.54 / -0.15 (-1.95%) 05/19/23 Biotech Alert: Searches spiking for these stocks today 04/13/23 Biotech Alert: Searches spiking for these stocks today 03/30/23 Biotech Alert: Searches spiking for these stocks today 03/27/23 What You Missed On Wall Street On Monday 06/02/23 2023 ASCO Annual Meeting 06/06/23 Iovance Biotherapeutics, Inc.
Hot Stocks	Agra Ventures enters agreement to extend maturity date for debentures » 07:33 05/30/23 05/30 07:33 05/30/23 07:33 AGFAF Agra Ventures / + Agra Ventures entered… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:33 Get Free Trial ShowHide Related Items >><< Company News AGFAF Agra Ventures / + 05/23/23 Agra Ventures receives earnout milestone payment from Organigram 02/23/23 Agra Ventures appoints Kuzyk as permanent CEO, director
Hot Stocks	Canopy Growth, Indiva announce license assignment, assumption agreement » 07:33 05/30/23 05/30 07:33 05/30/23 07:33 CGC Canopy Growth / + Canopy Growth and Indiva… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:33 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CGC Canopy Growth / + 05/22/23 Canopy Growth files proxy statement, modifies structure, for listing compliance 05/09/23 Acreage Holdings CFO Steve Goertz resigns 04/27/23 Bipartisan lawmakers reintroduce Safe Banking Act for cannabis businesses 03/21/23 Acreage obtains final order for strategic arrangement with Canopy Growth CGC Canopy Growth / + 05/23/23 BofA Canopy risk of NASDAQ delisting eased by revised proxy, says BofA 05/02/23 Piper Sandler Canopy Growth price target lowered to $1 from $2 at Piper Sandler 05/01/23 BMO Capital Canopy Growth upgraded to Market Perform from Underperform at BMO Capital 04/04/23 Bernstein Canopy Growth upgraded to Market Perform from Underperform at Bernstein CGC Canopy Growth / + 04/06/23 Constellation Brands reports Q4 comparable EPS ex-Canopy $2.15 02/09/23 Canopy Growth reports Q3 EPS (C$0.54) vs. (C$0.28) a year ago CGC Canopy Growth / + 04/21/23 Booker says lawmakers to revive cannabis banking bill, Marijuana Moment says 12/27/22 FDA explores regulating CBD in foods, supplements, WSJ reports 12/05/22 Defense bill with marijuana reform attached is delayed, Marijuana Moment says CGC Canopy Growth / + 05/11/23 Here's What You Missed in Cannabis, Psychedelics This Week 05/04/23 Here's What You Missed in Cannabis This Week 04/20/23 Here's What You Missed in Cannabis This Week 04/13/23 Here's What You Missed in Cannabis This Week CGC Canopy Growth / + 05/16/23 Largest borrow rate increases among liquid names 03/07/23 Largest borrow rate increases among liquid names 03/01/23 Largest borrow rate increases among liquid names 02/27/23 Largest borrow rate increases among liquid names
Earnings	Freeline reports Q1 EPS 2c vs (63c) last year » 07:32 05/30/23 05/30 07:32 05/30/23 07:32 FRLN Freeline $2.50 / +0.03 (+1.21%) "FLT201 is a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:32 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly FRLN Freeline $2.50 / +0.03 (+1.21%) 05/22/23 Freeline granted ILAP designation in U.K. by MHRA 05/12/23 Freeline completes ADS ratio change 04/21/23 Freeline announces proposed ADS ratio change 04/04/23 Freeline, Forcefield sign exclusive patent, know-how license agreement FRLN Freeline $2.50 / +0.03 (+1.21%) 04/06/23 BTIG Freeline price target lowered to $2 from $3 at BTIG 04/05/23 H.C. Wainwright Freeline price target lowered to $2 from $15 at H.C. Wainwright 04/04/23 Stifel Freeline downgraded to Hold from Buy at Stifel 02/27/23 Wedbush Wedbush upgrades Sangamo to Outperform, raises price target to $16 FRLN Freeline $2.50 / +0.03 (+1.21%) 04/04/23 Freeline reports FY22 EPS ($1.50), consensus ($1.99) FRLN Freeline $2.50 / +0.03 (+1.21%) 04/04/23 Fly Intel: Pre-market Movers
Hot Stocks	Aclarion announces new engagement with The Lordon Clinic, London Spine Clinic » 07:32 05/30/23 05/30 07:32 05/30/23 07:32 ACON Aclarion / + Aclarion announced their… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:32 Get Free Trial ShowHide Related Items >><< Company News Street Research ACON Aclarion / + 05/23/23 Aclarion announces Karahalios will advise as a KOL 05/23/23 Aclarion announces delayed 10-Q filing 05/19/23 Aclarion announces non-convertible debt financing 05/02/23 Aclarion appoints Nicholas Theodore as Principal Investigator ACON Aclarion / + 07/06/22 Maxim Aclarion initiated with a Buy at Maxim 07/06/22 Maxim Aclarion initiated with a Buy at Maxim
Recommendations	Mesoblast price target lowered to $2 from $2.50 at Chardan » 07:30 05/30/23 05/30 07:30 05/30/23 07:30 MESO Mesoblast $3.62 / +0.19 (+5.54%) Chardan analyst Keay… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:30 Get Free Trial ShowHide Related Items >><< Company News Street Research Events MESO Mesoblast $3.62 / +0.19 (+5.54%) 04/03/23 Reunion Neuroscience appoints Grossman to board of directors 03/21/23 Mesoblast says FDA schedules pre-license inspection of Remestemcel-L production 03/07/23 Mesoblast says FDA accepts resubmission of BLA for remestemcel-L 02/08/23 Mesoblast says FDA grants RMAT designation for rexlemestrocel-L MESO Mesoblast $3.62 / +0.19 (+5.54%) 03/09/23 William Blair Mesoblast initiated with an Outperform at William Blair 12/06/22 Jefferies Mesoblast downgraded to Hold from Buy at Jefferies 09/06/22 Piper Sandler Mesoblast initiated with an Overweight at Piper Sandler 06/03/22 Chardan Mesoblast price target lowered to $2.50 from $6.50 at Chardan 08/02/23 PDUFA Date for Remestemcel-L
Hot Stocks	Alterity Therapeutics initiates second Phase 2 study of ATH434 » 07:28 05/30/23 05/30 07:28 05/30/23 07:28 ATHE Alterity Therapeutics $2.69 / -0.065 (-2.36%) Alterity Therapeutics has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:28 Get Free Trial ShowHide Related Items >><< Company News Street Research ATHE Alterity Therapeutics $2.69 / -0.065 (-2.36%) 05/10/23 Alterity Therapeutics enrolls first patient in Australia in ATH434 Phase 2 trial 05/10/23 Alterity Therapeutics reports cash balance of A$21.9M as of March 31 04/26/23 Alterity Therapeutics presents wearable sensor data from bioMUSE study 04/04/23 Alterity Therapeutics enrolls first patient in UK in ATH434 Phase 2 trial ATHE Alterity Therapeutics $2.69 / -0.065 (-2.36%) 09/26/22 Benchmark Alterity data show validation of wearable sensor use, says Benchmark 08/03/22 Ladenburg Ladenburg starts Alterity at Buy, sees potential for MSA path as 'shortcut' 08/03/22 Ladenburg Alterity Therapeutics initiated with a Buy at Ladenburg

Recommendations	Hasbro price target raised to $75 from $70 at Stifel » 07:27 05/30/23 05/30 07:27 05/30/23 07:27 HAS Hasbro $60.08 / +0.325 (+0.54%) Stifel raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:27 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HAS Hasbro $60.08 / +0.325 (+0.54%) 04/12/23 Hasbro names Gina Goetter CFO 02/16/23 Hasbro CFO expects operating cash flow to 'nearly double' in 2023 01/26/23 Hasbro falls 4% to $61.21 after below-consensus Q4 pre-announcement 01/26/23 Hasbro COO Eric Nyman steps down HAS Hasbro $60.08 / +0.325 (+0.54%) 05/17/23 BofA Hasbro price target raised to $68 from $63 at BofA 04/28/23 Stifel Hasbro price target raised to $70 from $68 at Stifel 04/28/23 BofA Hasbro upgraded to Neutral from Underperform at BofA 04/13/23 BofA Harley-Davidson price target lowered to $55 from $65 at BofA HAS Hasbro $60.08 / +0.325 (+0.54%) 04/27/23 Hasbro backs 2023 adjusted EPS view $4.45-$4.55, consensus $4.38 04/27/23 Hasbro reports Q1 adjusted EPS 1c, consensus 1c 04/26/23 Notable companies reporting before tomorrow's open 04/26/23 Notable companies reporting before tomorrow's open HAS Hasbro $60.08 / +0.325 (+0.54%) 01/10/23 Paramount+ orders live-action show based on 'Dungeons & Dragons,' TC says HAS Hasbro $60.08 / +0.325 (+0.54%) 04/27/23 Fly Intel: Pre-market Movers 04/12/23 Fly Intel: After-Hours Movers 02/16/23 What You Missed On Wall Street On Thursday 02/16/23 What You Missed On Wall Street This Morning 06/06/23 Hasbro HAS Hasbro $60.08 / +0.325 (+0.54%) 04/28/23 Early notable gainers among liquid option names on April 28th 04/27/23 Early notable gainers among liquid option names on April 27th 04/10/23 Hasbro call volume above normal and directionally bullish 02/10/23 Unusually active option classes on open February 10th
Recommendations	Air Products price target raised to $385 from $375 at TD Cowen » 07:27 05/30/23 05/30 07:27 05/30/23 07:27 APD Air Products $273.77 / +0.9 (+0.33%) TD Cowen analyst Marc… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:27 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings APD Air Products $273.77 / +0.9 (+0.33%) 05/25/23 Air Products to acquire natural gas-to-syngas facility in Uzbekistan for $1B 05/18/23 Air Products extends term of CEO, chairman Seifi Ghasemi 05/15/23 Aers Energy Belgie selects Air Products to build hydrogen refueling station 05/10/23 Air Products announces $10M investment to increase membrane production capacity APD Air Products $273.77 / +0.9 (+0.33%) 05/15/23 Evercore ISI Air Products removed from 'Tactical Outperform' list at Evercore ISI 05/12/23 Deutsche Bank Air Products price target lowered to $325 from $340 at Deutsche Bank 05/10/23 Mizuho Air Products price target lowered to $322 from $325 at Mizuho 03/24/23 BMO Capital Air Products price target lowered to $360 from $386 at BMO Capital APD Air Products $273.77 / +0.9 (+0.33%) 05/09/23 Air Products sees Q3 adjusted EPS $2.85-$2.95, consensus $2.92 05/09/23 Air Products narrows FY23 adjusted EPS view to $11.30-$11.50 from $11.20-$11.50 05/09/23 Air Products reports Q2 adjusted EPS $2.74, consensus $2.64 02/02/23 Air Products backs FY23 adjusted EPS view $11.20-$11.50, consensus $11.39
Recommendations	PG&E price target raised to $21 from $20 at RBC Capital » 07:26 05/30/23 05/30 07:26 05/30/23 07:26 PCG PG&E $16.52 / +0.095 (+0.58%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:26 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Options PCG PG&E $16.52 / +0.095 (+0.58%) 05/15/23 Third Point buys Alibaba, cuts AIG in Q1 03/15/23 PG&E names Carolyn Burke as CFO, effective May 4 03/02/23 PG&E says NRC approves request related to continued operations at DCPP 02/14/23 Third Point buys AIG, exits T-Mobile in Q4 PCG PG&E $16.52 / +0.095 (+0.58%) 04/03/23 Ladenburg PG&E initiated with a Buy at Ladenburg 02/02/23 BofA Interactive Brokers, Knight-Swift, PG&E added to 'US 1' list at BofA 02/01/23 Wells Fargo Wells downgrades Edison International, recommends swap into PG&E 01/23/23 Guggenheim Guggenheim lays out 2023 utilities outlook, upgrades two, downgrades six stocks PCG PG&E $16.52 / +0.095 (+0.58%) 05/04/23 PG&E backs FY23 EPS view $1.19-$1.23, consensus $1.21 05/04/23 PG&E reports Q1 EPS 29c, consensus 29c 02/23/23 PG&E backs FY23 EPS view $1.19-$1.23, consensus $1.22 02/23/23 PG&E reports Q4 core EPS 26c, consensus 28c 12 Apr 10 Jan 13 Dec 28 Oct 05 Oct PCG PG&E $16.52 / +0.095 (+0.58%) 05/17/23 PG&E call volume above normal and directionally bullish 02/24/23 Early notable gainers among liquid option names on February 24th 02/07/23 PG&E call volume above normal and directionally bullish 02/06/23 PG&E call volume above normal and directionally bullish
Recommendations	Monolithic Power price target raised to $625 from $500 at TD Cowen » 07:25 05/30/23 05/30 07:25 05/30/23 07:25 MPWR Monolithic Power $520.81 / +34.25 (+7.04%) TD Cowen raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:25 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MPWR Monolithic Power $520.81 / +34.25 (+7.04%) 05/05/23 Monolithic Power CEO Hsing sells 3,825 common shares 02/13/23 Monolithic Power CEO sells $3.12M in common stock 12/12/22 Monolithic Power signs semiconductor supply agreement with VIS 12/11/22 Fly Intel: Top five weekend stock stories MPWR Monolithic Power $520.81 / +34.25 (+7.04%) 05/05/23 Deutsche Bank Monolithic Power price target lowered to $475 from $505 at Deutsche Bank 05/05/23 Truist Monolithic Power price target lowered to $527 from $608 at Truist 05/05/23 Wells Fargo Monolithic Power price target lowered to $510 from $525 at Wells Fargo 05/05/23 TD Cowen Monolithic Power price target lowered to $500 from $550 at TD Cowen MPWR Monolithic Power $520.81 / +34.25 (+7.04%) 05/04/23 Monolithic Power sees Q2 revenue $430M-$450M, consensus $455.45M 05/04/23 Monolithic Power reports Q1 EPS $3.00, consensus $2.96 02/08/23 Monolithic Power sees Q1 revenue $440M-$460M, consensus $448.47M. 02/08/23 Monolithic Power reports Q4 EPS $2.45, consensus $3.14 MPWR Monolithic Power $520.81 / +34.25 (+7.04%) 12/10/22 Microsoft, Arista among stocks that can survive a triple whammy, Barron's says MPWR Monolithic Power $520.81 / +34.25 (+7.04%) 05/04/23 Fly Intel: After-Hours Movers 06/14/23 2023 Semiconductor Bus Tour 06/15/23 Monolithic Power Systems, Inc. MPWR Monolithic Power $520.81 / +34.25 (+7.04%) 05/26/23 Early notable gainers among liquid option names on May 26th 05/25/23 Early notable gainers among liquid option names on May 25th 05/10/23 Early notable gainers among liquid option names on May 10th 02/09/23 Early notable gainers among liquid option names on February 9th
Recommendations	SilverBow Resources price target lowered to $39 from $44 at Truist » 07:25 05/30/23 05/30 07:25 05/30/23 07:25 SBOW SilverBow Resources $23.65 / -0.5 (-2.07%) Truist analyst Neal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 07:25 Get Free Trial ShowHide Related Items >><< Street Research Earnings Events SBOW SilverBow Resources $23.65 / -0.5 (-2.07%) 04/11/23 Truist SilverBow Resources price target raised to $51 from $37 at Truist 12/08/22 KeyBanc SilverBow Resources price target lowered to $48 from $58 at KeyBanc 10/04/22 Northland SilverBow Resources assumed with an Outperform at Northland 09/19/22 KeyBanc SilverBow Resources initiated with an Overweight at KeyBanc SBOW SilverBow Resources $23.65 / -0.5 (-2.07%) 03/01/23 SilverBow Resources reports Q4 EPS $7.65, consensus $2.80 05/21/24 SilverBow Resources, Inc.

Events

Earnings calls, analyst events, roadshows and more

GLNG
Today at 08:00

Golar LNG - GLNG Conference Calls
BNR
Today at 08:00

Burning Rock Biotech - BNR Conference Calls
TIGR
Today at 08:00

UP Fintech - TIGR Conference Calls
GOTU
Today at 08:00

Gaotu Techedu - GOTU Conference Calls
TCRR
Today at 08:00

TCR2 Therapeutics Inc. Firm Sponsored Meetings
MDWD
Today at 08:30

MediWound - MDWD Conference Calls
YTRA
Today at 08:30

Yatra - YTRA Conference Calls
Today at 09:00

Case-Shiller Home Price Index: 20-City Adjusted M/M: March 2023 Government Event
Today at 09:00

Case-Shiller Home Price Index: 20-City Unadjusted M/M: March 2023 Government Event
Today at 09:00

Case-Shiller Home Price Index: 20-City Unadjusted Y/Y: March 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	AZTR X AZTR Azitra IPO Managers: ThinkEquity $4.50-5.50 2.4M Shares SXTP X SXTP 60 Degrees Pharmaceuticals IPO Managers: WallachBeth $4.30-6.30 1.415M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Panbela Therapeutics resumed with a Buy at Roth Capital

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access